Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Baxter
Dow
Medtronic
Moodys

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Nexgen Pharma Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has seventeen approved drugs.



Summary for Nexgen Pharma Inc
US Patents:0
Tradenames:16
Ingredients:16
NDAs:17

Drugs and US Patents for Nexgen Pharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma Inc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 209587-001 Oct 31, 2018 AA RX No No   Start Trial   Start Trial
Nexgen Pharma Inc SODIUM PENTOBARBITAL pentobarbital sodium TABLET;ORAL 084238-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Nexgen Pharma Inc PROPOXYPHENE HYDROCHLORIDE propoxyphene hydrochloride CAPSULE;ORAL 083185-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Nexgen Pharma Inc BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE acetaminophen; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 076560-002 Jul 19, 2012 RX No No   Start Trial   Start Trial
Nexgen Pharma Inc DIMENHYDRINATE dimenhydrinate TABLET;ORAL 085985-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Nexgen Pharma Inc NABUMETONE nabumetone TABLET;ORAL 203166-001 Aug 30, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
AstraZeneca
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.